Several Applications of Solid Lipid Nanoparticles in Drug Delivery

Overview

Journal Curr Mol Med

Publisher Bentham Science Publishers

Specialty Molecular Biology

Date 2023 Jul 21

PMID 37475554

Authors

Noor Hassan Sulaiman Khil

Shaweta Sharma

Pramod Kumar Sharma

Aftab Alam

Affiliations

Soon will be listed here.

Abstract

Rapid progress is being made in the area of nanotechnology; solid lipid nanoparticles are currently at the forefront of research and development. They have the capability of becoming employed in an extensive number of applications, including the delivery of medications, clinical treatment, and research, in addition to uses in other areas of academic inquiry that could benefit from their utilisation. This article presents a thorough analysis of solid lipid nanoparticles, covering subjects such as their goals, preparation strategy, applications, advantages, and possible remedies for the issues that have been raised. This review provides a discussion of solid lipids that is both in-depth and comprehensive. Studies that investigate the manner in which SLNs are prepared and the routes via which they are administered are typical. Aspects concerning the route of administration of SLNs as well as the destiny of the carriers in vivo are also investigated in this paper.

References

Paliwal R, Rai S, Vaidya B, Khatri K, Goyal A, Mishra N . Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine. 2008; 5(2):184-91. DOI: 10.1016/j.nano.2008.08.003. View

Cortesi R, Esposjto E, Luca G, Nastruzzi C . Production of lipospheres as carriers for bioactive compounds. Biomaterials. 2002; 23(11):2283-94. DOI: 10.1016/s0142-9612(01)00362-3. View

Scheffel U, Rhodes B, Natarajan T, Wagner Jr H . Albumin microspheres for study of the reticuloendothelial system. J Nucl Med. 1972; 13(7):498-503. View

Silva A, Gonzalez-Mira E, Garcia M, Egea M, Fonseca J, Silva R . Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf B Biointerfaces. 2011; 86(1):158-65. DOI: 10.1016/j.colsurfb.2011.03.035. View

Manjunath K, Reddy J, Venkateswarlu V . Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol. 2005; 27(2):127-44. DOI: 10.1358/mf.2005.27.2.876286. View

Das S, Chaudhury A . Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech. 2010; 12(1):62-76. PMC: 3066374. DOI: 10.1208/s12249-010-9563-0. View

Mehnert W, Mader K . Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001; 47(2-3):165-96. DOI: 10.1016/s0169-409x(01)00105-3. View

Uner M, Yener G . Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine. 2007; 2(3):289-300. PMC: 2676658. View

Patil-Gadhe A, Kyadarkunte A, Patole M, Pokharkar V . Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance. Eur J Pharm Biopharm. 2014; 88(1):169-77. DOI: 10.1016/j.ejpb.2014.07.007. View

10.

Paranjpe M, Muller-Goymann C . Nanoparticle-mediated pulmonary drug delivery: a review. Int J Mol Sci. 2014; 15(4):5852-73. PMC: 4013600. DOI: 10.3390/ijms15045852. View

11.

Mishra V, Bansal K, Verma A, Yadav N, Thakur S, Sudhakar K . Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems. Pharmaceutics. 2018; 10(4). PMC: 6321253. DOI: 10.3390/pharmaceutics10040191. View

12.

Mukherjee S, Ray S, Thakur R . Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2010; 71(4):349-58. PMC: 2865805. DOI: 10.4103/0250-474X.57282. View

13.

Parhi R, Suresh P . Preparation and characterization of solid lipid nanoparticles-a review. Curr Drug Discov Technol. 2012; 9(1):2-16. DOI: 10.2174/157016312799304552. View

14.

Souto E, Wissing S, Barbosa C, Muller R . Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004; 278(1):71-7. DOI: 10.1016/j.ijpharm.2004.02.032. View

15.

Pardeike J, Hommoss A, Muller R . Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2008; 366(1-2):170-84. DOI: 10.1016/j.ijpharm.2008.10.003. View

16.

Naguib Y, Rodriguez B, Li X, Hursting S, Williams 3rd R, Cui Z . Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation. Mol Pharm. 2014; 11(4):1239-49. PMC: 3993949. DOI: 10.1021/mp4006968. View

17.

Venkateswarlu V, Manjunath K . Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 2004; 95(3):627-38. DOI: 10.1016/j.jconrel.2004.01.005. View

18.

Hu F, Yuan H, Zhang H, Fang M . Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm. 2002; 239(1-2):121-8. DOI: 10.1016/s0378-5173(02)00081-9. View

19.

Trotta M, Debernardi F, Caputo O . Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm. 2003; 257(1-2):153-60. DOI: 10.1016/s0378-5173(03)00135-2. View

20.

Yuan H, Huang L, Du Y, Ying X, You J, Hu F . Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf B Biointerfaces. 2007; 61(2):132-7. DOI: 10.1016/j.colsurfb.2007.07.015. View